Da. Wheeler et al., WEIGHT-LOSS AS A PREDICTOR OF SURVIVAL AND DISEASE PROGRESSION IN HIV-INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 18(1), 1998, pp. 80-85
Severe weight loss in HIV is associated with decreased length of survi
val. It is unclear whether mild weight loss is associated with an incr
eased risk of death or opportunistic complications of HIV. Participant
s in four interventional studies (n = 2382) conducted by a community-b
ased clinical trials network were evaluated for percentage change in w
eight during their first 4 months in the study. Proportional hazards m
odels were performed for the occurrence of opportunistic complications
and death subsequent to the if-month visit. The relative risk of deat
h and opportunistic complications for those with 5% to 10% weight loss
over 4 months was 2.22 (p <.001) and 1.89 (p <.001), respectively, an
d 1.26 (p <.01) and 1.19 (p <.01) among those who lost 0% to 5% of the
ir body weight, respectively, when compared with those with no weight
loss. Among those who lost 5% to 10% of their body weight, the relativ
e risk of individual opportunistic complications increased significant
ly, including Pneumocystis carinii pneumonia (PCP) (1.61; p <.01), cyt
omegalovirus (CMV) (2.33; p < .001), and Mycobacterium avium complex (
MAC) (1.81; p <.01). As little as 5%t weight loss over a 4-month perio
d is associated with increased risk of death and opportunistic complic
ations in HIV. A weight loss of 5% to 10% is also associated with an i
ncreased risk of individual opportunistic complications.